Schonfeld Strategic Advisors LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$459,472
-50.3%
16,398
-50.2%
0.00%
-50.0%
Q3 2022$924,000
+241.0%
32,900
+321.8%
0.01%
+166.7%
Q2 2022$271,000
-66.4%
7,800
-65.3%
0.00%
-57.1%
Q1 2022$807,000
-40.4%
22,500
-67.9%
0.01%
-78.8%
Q4 2019$1,354,000
+278.2%
70,179
+312.8%
0.03%
+153.8%
Q2 2019$358,000
-59.7%
17,000
-60.9%
0.01%
-58.1%
Q1 2019$888,000
+88.9%
43,500
+70.2%
0.03%
-49.2%
Q4 2016$470,00025,5610.06%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders